Sugar-sweetened beverages, low/no-calorie beverages, fruit juice and non-alcoholic fatty liver disease defined by fatty liver index: the SWEET project

[1]  Lawrence A Leiter,et al.  Association of Low- and No-Calorie Sweetened Beverages as a Replacement for Sugar-Sweetened Beverages With Body Weight and Cardiometabolic Risk , 2022, JAMA network open.

[2]  F. Hu,et al.  The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases , 2022, Nature Reviews Endocrinology.

[3]  U. Hoffmann,et al.  Sugar-Sweetened Beverage, Diet Soda, and Non-Alcoholic Fatty Liver Disease Over 6 Years: The Framingham Heart Study. , 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  E. Feskens,et al.  Development and external validation of the "Flower-FFQ": a food frequency questionnaire designed for the Lifelines Cohort Study. , 2021, Public health nutrition.

[5]  A. Stein,et al.  Associations between Free Sugar and Sugary Beverage Intake in Early Childhood and Adult NAFLD in a Population-Based UK Cohort , 2021, Children.

[6]  L. Qi,et al.  Soft drink consumption and risk of nonalcoholic fatty liver disease: results from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) cohort study. , 2021, The American journal of clinical nutrition.

[7]  J. Martínez,et al.  A rational review on the effects of sweeteners and sweetness enhancers on appetite, food reward and metabolic/adiposity outcomes in adults. , 2020, Food & function.

[8]  F. Sofi,et al.  100% Fruit juice intake and cardiovascular risk: a systematic review and meta-analysis of prospective and randomised controlled studies , 2020, European Journal of Nutrition.

[9]  V. Wong,et al.  The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease , 2020, Hepatology International.

[10]  Lijun Li,et al.  Recent advances in fructose intake and risk of hyperuricemia. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  Lawrence A Leiter,et al.  Association of Major Food Sources of Fructose-Containing Sugars With Incident Metabolic Syndrome , 2020, JAMA network open.

[12]  J. Martínez,et al.  Influence of lifestyle factors and staple foods from the Mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features. , 2019, Nutrition.

[13]  L. Chiavaroli,et al.  A lack of consideration of a dose–response relationship can lead to erroneous conclusions regarding 100% fruit juice and the risk of cardiometabolic disease , 2019, European Journal of Clinical Nutrition.

[14]  M. Dehghani,et al.  Association of sugar sweetened beverages consumption with non-alcoholic fatty liver disease: a systematic review and meta-analysis , 2019, European Journal of Nutrition.

[15]  S. Hinkle,et al.  A prospective study of artificially sweetened beverage intake and cardiometabolic health among women at high risk. , 2019, The American journal of clinical nutrition.

[16]  Wei Zhang,et al.  Consumption of Sugar-Sweetened Beverages Has a Dose-Dependent Effect on the Risk of Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Dose-Response Meta-Analysis , 2019, International journal of environmental research and public health.

[17]  Rohit Loomba,et al.  Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. , 2019, Gastroenterology.

[18]  Iryna Liauchonak,et al.  Non-Nutritive Sweeteners and Their Implications on the Development of Metabolic Syndrome , 2019, Nutrients.

[19]  J. Rivera,et al.  Dietary Sources of Fructose and Its Association with Fatty Liver in Mexican Young Adults , 2019, Nutrients.

[20]  J. Martínez,et al.  Cohort Profile: Design and methods of the PREDIMED-Plus randomized trial. , 2018, International journal of epidemiology.

[21]  E. Feskens,et al.  Nutrition Questionnaires plus (NQplus) study, a prospective study on dietary determinants and cardiometabolic health in Dutch adults , 2018, BMJ Open.

[22]  K. Nadeau,et al.  Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. , 2018, Journal of hepatology.

[23]  Yong Zhang,et al.  Validation of simple indexes for nonalcoholic fatty liver disease in western China: a retrospective cross-sectional study. , 2018, Endocrine journal.

[24]  V. Pīrāgs,et al.  Fatty liver index and hepatic steatosis index for prediction of non‐alcoholic fatty liver disease in type 1 diabetes , 2018, Journal of gastroenterology and hepatology.

[25]  Michael Charlton,et al.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases , 2018, Hepatology.

[26]  Tyler J. VanderWeele,et al.  Sensitivity Analysis in Observational Research: Introducing the E-Value , 2017, Annals of Internal Medicine.

[27]  K. Faber,et al.  Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort , 2017, PloS one.

[28]  K. Stote,et al.  Metabolic impact of 100% fruit juice consumption on antioxidant/oxidant status and lipid profiles of adults: An Evidence-Based review , 2017, Critical reviews in food science and nutrition.

[29]  T. Khan,et al.  Controversies about sugars: results from systematic reviews and meta-analyses on obesity, cardiometabolic disease and diabetes , 2016, European Journal of Nutrition.

[30]  K. Rother,et al.  Trends in the consumption of low-calorie sweeteners , 2016, Physiology & Behavior.

[31]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[32]  H. Tilg,et al.  EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. , 2016, Journal of hepatology.

[33]  Guang Ning,et al.  Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese , 2015, Medicine.

[34]  H. Snieder,et al.  Representativeness of the LifeLines Cohort Study , 2015, PloS one.

[35]  C. Fox,et al.  Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts. , 2015, Journal of hepatology.

[36]  V. Medici,et al.  A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults. , 2015, The American journal of clinical nutrition.

[37]  Hwai I. Yang,et al.  External Validation of Fatty Liver Index for Identifying Ultrasonographic Fatty Liver in a Large-Scale Cross-Sectional Study in Taiwan , 2015, PloS one.

[38]  F. Nascimbeni,et al.  Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease , 2014, Alimentary pharmacology & therapeutics.

[39]  J. Mann,et al.  Dietary sugars and cardiometabolic risk: systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids. , 2014, The American journal of clinical nutrition.

[40]  A. Hofman,et al.  External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[41]  E. Feskens,et al.  Relative validity of the food frequency questionnaire used to assess dietary intake in the Leiden Longevity Study , 2013, Nutrition Journal.

[42]  M. Hochuli,et al.  Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. , 2011, The American journal of clinical nutrition.

[43]  A. Astrup,et al.  Increased postprandial glycaemia, insulinemia, and lipidemia after 10 weeks’ sucrose-rich diet compared to an artificially sweetened diet: a randomised controlled trial , 2011, Food & nutrition research.

[44]  J. Geleijnse,et al.  n-3 fatty acids and cardiovascular events after myocardial infarction. , 2010, The New England journal of medicine.

[45]  François Mariotti,et al.  Dose‐response analyses using restricted cubic spline functions in public health research , 2010, Statistics in medicine.

[46]  J. Geleijnse,et al.  Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial. , 2010, American heart journal.

[47]  M. Martínez-González,et al.  Reproducibility of an FFQ validated in Spain , 2010, Public Health Nutrition.

[48]  Dolores Corella,et al.  Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain , 2010, British Journal of Nutrition.

[49]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[50]  Willem van Mechelen,et al.  Reliability and validity of the Activity Questionnaire for Adults and Adolescents (AQuAA) , 2009, BMC medical research methodology.

[51]  M. Kenward,et al.  Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls , 2009, BMJ : British Medical Journal.

[52]  Anna Castiglione,et al.  The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population , 2006, BMC gastroenterology.

[53]  Barbara Williams,et al.  The Rapid Assessment of Physical Activity (RAPA) Among Older Adults , 2006, Preventing chronic disease.

[54]  J. Martínez,et al.  Validation of the Spanish version of the physical activity questionnaire used in the Nurses' Health Study and the Health Professionals' Follow-up Study , 2005, Public Health Nutrition.

[55]  W. Saris,et al.  Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. , 2003, Journal of clinical epidemiology.

[56]  K. Westerterp,et al.  Validity of the Physical Activity Scale for the Elderly (PASE): according to energy expenditure assessed by the doubly labeled water method. , 1997, Journal of clinical epidemiology.

[57]  J. Hautvast,et al.  Relative and biomarker-based validity of a food-frequency questionnaire estimating intake of fats and cholesterol. , 1993, The American journal of clinical nutrition.

[58]  M. Dumont,et al.  European Association for the Study of the Liver , 1971 .

[59]  K. Lundbaek,et al.  European Association for the study of diabetes , 1969, Diabetologia.

[60]  OUP accepted manuscript , 2021, International Journal Of Epidemiology.

[61]  E. Feskens,et al.  Associations between dietary factors and markers of NAFLD in a general Dutch adult population , 2018, European Journal of Clinical Nutrition.

[62]  M. Singer,et al.  Nutritional Epidemiology , 2020, Definitions.